POPULARITY
6 episodes with aspergillosis
5 episodes with aspergillosis
2 episodes with aspergillosis
2 episodes with aspergillosis
2 episodes with aspergillosis
2 episodes with aspergillosis
3 episodes with aspergillosis
2 episodes with aspergillosis
2 episodes with aspergillosis
From the 2024 Society for Leukocyte Biology meeting, Immune talks with Amy Hise about her career in science, her current research using mouse models for investigating fungal immunity and navigating the challenges of being a mom in science. Hosts: Cindy Leifer and Brianne Barker Guest: Amy Hise MicrobeTV Discord Server Mouse model for testing drugs to treat Candida fungal infection Inflammasomes in Aspergillosis Society for Leukocyte Biology Subscribe (free): Apple Podcasts, RSS, email Become a patron of Immune! Music by Tatami. Logo image by Blausen Medical Send your immunology questions and comments to immune@microbe.tv Content in this podcast should not be construed as medical advice.
VOV1 - Hôm nay, Bệnh viện Phổi Trung ương tổ chức Hội thảo khoa học “Ngày nấm toàn cầu 2025” với sự tham gia của hàng nghìn bác sỹ, nhà khoa học trong nước và quốc tế. Đây là hoạt động hưởng ứng Ngày phòng chống bệnh Nấm Aspergillosis toàn cầu, giúp tăng cường chẩn đoán, điều trị bệnh tại Việt Nam
On episode #69 of the Infectious Disease Puscast, Sara reviews the infectious disease literature for the weeks of 11/21 – 12/4/24. Host: Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Antiretroviral Drugs for Treatment and Prevention of HIV in Adults(JAMA Network) Human Parvovirus B19 Infections Among Pregnant Persons — Minnesota, January–September 2024 (CDC MMWR) Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients (Journal of Heart and Lung Transplantation) Bacterial Choosing Wisely: Effectiveness and Safety of Antibiotic Prophylaxis in Close Contacts of InvasiveGroup A Streptococci Infection (CID) Resurgence of pediatric Mycoplasma pneumoniae infections in Southeast Texas, Nov 2023-June 2024 (Journal of Pediatrics Infectious Diseases Society) Fungal The Last of US Season 2 (YouTube) Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants(Transplant Infectious Disease) Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysis (LANCET: Infectious Diseases) Parasitic Waterborne Disease Outbreaks Associated with Splash Pads — United States, 1997–2022 (CDC MMWR) Miscellaneous Skin Color Representation in Infectious Disease Textbooks (OFID) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.
Send us a textIn this episode, we discuss the history, epidemiology, clinical presentation, investigations and management for invasive aspergillosis. Written by: Dr. Ravinder Sandhu (Internal Medicine Resident)Reviewed by: Dr. Terrence Ho (Respirology) and Dr. John Neary (General Internal Medicine)Sound Editing by: Tony WalshSupport the show
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Ritesh Agarwal (Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India) about the revised International Society for Human and Animal Mycology ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.
Dr. Guy Handley, Assistant Professor at the USF Morsani Division of Infectious Diseases and International Medicine, presents a talk on Fungal pneumonias in immunocompromised patients. Dr. Handley begins by discussing the differential diagnosis of pneumonia, and then an overview of the most common types of mold pneumonias by pathogen. He then shares a case presentation of a mold pneumonia and discusses options in a question and answer format utilizing PollEv. Next, Dr. Handley focuses on Aspergillosis , then Zygomycosis, and compares and contrasts the two. Diagnostic and treatment options are explored for the invasive molds. Lastly, future directions in mold therapy are mentioned, including Fosmanogepix, ibrexafungerp, Rezafungin, and others.
In this episode, we review the high-yield topic of Allergic Bronchopulmonary Aspergillosis (ABPA) from the Pulmonary section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets
Some people in the cannabis industry are questioning whether it is appropriate or necessary to test inhaled cannabis products for pathogenic Aspergillus. Full disclosure, we at Medicinal Genomics sell qPCR testing kits designed to detect pathogenic Aspergillus on cannabis products. We have also published several resources on our website that describe the potential harms that can be caused by inhaling pathogenic Aspergillus spores and cite with more than 2 dozen Aspergilosis cases in cannabis users. We have also recommended that states that are considering cannabis testing regulations adopt pathogenic Aspergillus testing. Not because we sell Aspergillus tests, but because we want to protect patients. By almost any measure, cannabis is one of the most safe and effective medicines available. And in many cases, the potential harms that can come from using cannabis are not caused by the plant, but rather contaminants. And although cases are rare, The documented cases describing Aspergillosis deaths from contaminated cannabis vastly outnumber the published clinical risks for every other contaminant for which the cannabis industry tests. There are no documented deaths for cannabis-derived heavy metals, mycotoxins, pesticides or incorrect cannabinoid labeling. The same cannot be said So that is our position, but of course we acknowledge that we are biased, and we are not experts on pathogenic fungi; however, our guest today is. David W. Denning is a Professor of Infectious Diseases in Global Health at the University of Manchester in the United Kingdom. He was the founding president, executive director, and CEO of Global Action For Fungal Infections, an organization dedicated to reducing the worldwide burden of fungal disease. In 2016, he became the director of the National Aspergillosis Centre in Manchester, which treats patients with chronic pulmonary aspergillosis (CPA), and led the committee that developed the first CPA guidelines. He chairs the editorial board of a website which focusses on aspergillus and he leads an organisation which provides education on fungal diseases. In short, Dr. Denning is the leading authority on all things Aspergillus, and we asked him many of the questions that have been debated on social media recently, including: Should cannabis be tested for pathogenic Aspergillus Should there be an allowable limit for pathogenic Aspergillus? Is Apergillosis only a concern for immunocompromised patients? Are the number of Aspergillosis cases under reported? How difficult is Aspergillosis to diagnose and treat? How ubiquitous is Aspergillus in the air we breathe? and so much more. Thanks to This Episode's Sponsor: Modern Canna Modern Canna is regarded as Florida's first medical cannabis laboratory and one of the most trusted third party testing providers in the United States. The company's mission is to help set the standard for cannabis testing labs worldwide by providing the most accurate and efficient testing services, delivered with a sense of compassion, integrity, and moral obligation; and to attract and attain clients who value quality data that is verifiable, reproducible, and legally defensible. Modern Canna is the only Leafly Certified laboratory in the eastern United States and adheres to the industry's strictest SOPs and quality control standards. Modern Canna offers a wide variety of testing, rapid turnaround times, and consulting services to Florida Medical Marijuana Treatment Centers (MMTC's) and hemp businesses throughout the US. Learn more at moderncanna.com Additional Resources Too Many Mouldy Joints – Marijuana and Chronic Pulmonary Aspergillosis The Aspergillus website https://en.fungaleducation.org/ Submit an Abstract for CannMed 24 Review the Podcast! CannMed Archive CannMed Community Board [Facebook Group]
From antifungal resistance to disaster microbiology and tales of visible mold growing across the skin of patients following a tornado in Joplin, Missouri, Dr. Shawn Lockhart, Senior Clinical Laboratory Advisor in the Mycotic Diseases Branch at the CDC talks all things fungi—complete with references to pop TV shows and the recently released 7th Edition of Larone's Medically Important Fungi. Links mentioned: Larone's Medically Important Fungi: A Guide to Identification, 7th Edition (Use code: MCR20 at checkout for 20% off) CDC's Mycotic Diseases Branch conducts an annual training course on the identification of pathogenic molds.
On episode #25 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 3/23 – 3/29/23. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS Become a patron of Puscast! Links for this episode Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates (Nature) First evidence of locally acquired Dengue infection (CDC) Respiratory viral infections in recipients of cellular therapies (OFID) Evolving Japanese encephalitis situation in Australia (JTM) Attainment of target antibiotic levels by oral treatment of left-sided infective endocarditis (CID) Utility of PCR vs serology based testing in immunocompromised patients with Bartonella (OFID) Source-associated mobile genetic elements to identify zoonotic coli infections (OneHealth) The risk of urinary tract infection in vegetarians and non-vegetarians (Nature) Hydrocortisone in severe community acquired pneumonia (NEJM) Adjunctive dexamethasone treatment in adults with Listeria monocytogenes meningitis (The Lancet) Worsening spread of Candida auris in the United States (AIM) Origin, resistance, and spread of the emerging human fungal pathogen Candida auris (PLOS) Emergence of Candida auris (mBio) Invasive aspergillosis in liver transplant recipients (Transplant ID) Trends in reported babesiosis cases (CDC) PCR assay for diagnosis of tick-borne infections in children (OFID) Molecular evidence of widespread benzimidazole drug resistance in Ancylostoma caninum (PLOS) Emphasis of diversity, equity and inclusion on U.S Adult Infectious Disease Fellowship program websites (JID) Music is by Ronald Jenkees
Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.12.14.520265v1?rss=1 Authors: Mead, M. E., Alves de Castro, P., Steenwyk, J. B., Gangneux, J.-P., Hoenigl, M., Prattes, J., Rautemaa-Richardson, R., Guegan, H., Moore, C. B., Lass-Floerl, C., Reizine, F., Valero, C., van Rhijn, N., Bromley, M. J., Rokas, A., Goldman, G. H., Gago, S. Abstract: Secondary infections caused by the pulmonary fungal pathogen Aspergillus fumigatus are a significant cause of mortality in patients with severe Coronavirus Disease 19 (COVID-19). Even though epithelial cell damage and aberrant cytokine responses have been linked with susceptibility to COVID-19 associated pulmonary aspergillosis (CAPA), little is known about the mechanisms underpinning co-pathogenicity. Here, we analysed the genomes of 11 A. fumigatus isolates from patients with CAPA in three centres from different European countries. CAPA isolates did not cluster based on geographic origin in a genome-scale phylogeny of representative A. fumigatus isolates. Phenotypically, CAPA isolates were more similar to the A. fumigatus A1160 reference strain than to the Af293 strain when grown in infection-relevant stresses; except for interactions with human immune cells wherein macrophage responses were similar to those induced by the Af293 reference strain. Collectively, our data indicates that CAPA isolates are genomically diverse but are more similar to each other in their responses to infection-relevant stresses. A larger number of isolates from CAPA patients should be studied to identify genetic drivers of co-pathogenicity in patients with COVID-19. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC
In this episode, we review the high-yield topic of Aspergillosis from the Infectious Disease section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets
Next instalment of the aspergillosis podcast, where we move on to talk about chronic pulmonary aspergillosis and invasive aspergillosis. Hope you've had time to digest part 1, part 2 is filled with useful content about diagnostics again, including the utility or lack of as it might be of galactomannans and Beta D Glucans in aspergillosis. Thank you again to Dr Chris Kosmidis. Support the show
An interview with Dr Chris Kosmidis, Clinical Senior Lecturer at Wythenshawe Hospital and Aspergillosis centre about aspergillosis. Divided into two parts, the first part of our discussion covers ABPA for the generalist, and is a goldmine of information for diagnosing, treating and monitoring response in these patients. I now feel comfortable interpreting the serology, prescribing antifungals where appropriate and how to look out for a relapse which is a long way from where I started!References for this podcast include:Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29. PMID: 25354514.Godet et al. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial. Eur Respir J. 2022 Jun 16;59(6):2102218. doi: 10.1183/13993003.02218-2021. PMID: 34764182.Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Garg M, Aggarwal AN, Chakrabarti A. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2021 Sep 9;59(4):2101787. doi: 10.1183/13993003.01787-2021. PMID: 34503983.How do we treat aspergillosis? - Dr Chris Kosmidis - YouTubeSupport the show
Kennedy Bradley, an epidemiology fellow at the Department of Public Health, Philadelphia, and Sarah Gregory discuss a fatal infection associated with triazole-resistant Aspergillus fumigatus in Pennsylvania.
Join Yvonne Brandenburg, RVT, VTS SAIM and Jordan Porter RVT, LVT, VTS SAIM as we talk about: The other fungus among us! But this one is everywhere, and when I say everywhere, I mean… everywhere! It attacks the nose, it does not favor one species, it is a beast! Question of the Week Have you seen a feline sino-orbital aspergillosis? Resources We Mentioned in the Show https://vcahospitals.com/know-your-pet/aspergillosis-in-dogs https://www.merckvetmanual.com/generalized-conditions/fungal-infections/aspergillosis https://veterinarypartner.vin.com/default.aspx?pid=19239&id=4952634 https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-feline-health-center/health-information/feline-health-topics/aspergillosis Thanks so much for tuning in. Join us again next week for another episode! Want to earn some RACE approved CE credits for listening to the podcast? You can earn between 0.5-1.0 hour of RACE approved CE credit for each podcast episode you listen to. Join the Internal Medicine For Vet Techs Membership to earn and keep track of your continuing education hours as you get your learn on! Join now! http://internalmedicineforvettechsmembership.com/ Get Access to the Membership Site for your RACE approved CE certificates Sign up at https://internalmedicineforvettechsmembership.com Get Access to the Technician Treasure Trove Sign up at https://imfpp.org/treasuretrove Thanks for listening! – Yvonne and Jordan
We discuss invasive aspergillosis, with a focus on when to consider and how to make this difficult diagnosis in the general ICU population—with Dr. Shmuel Shoham (@ShohamTxID), Associate Professor of Medicine at Johns Hopkins, transplant infectious disease physician, and an extensively published expert in invasive fungal infections as well as host of the Transplant ID … Continue reading "Episode 49: Invasive pulmonary aspergillosis with Shmuel Shoham"
Allergic bronchopulmonary aspergillosis (or ABPA) is a hypersensitivity reaction that some people get in response to having the mould aspergillus in their lungs. It is most often seen in people with asthma or cystic fibrosis. Follow us on Instagram @yourekiddingrightdoctors Our email is yourekiddingrightpod@gmail.com Make sure you hit SUBSCRIBE/FOLLOW so you don't miss out on any pearls of wisdom and RATE if you can to help other people find us! (This isn't individual medical advice, please use your own clinical judgement and local guidelines when caring for your patients)
This week we answer a question you probably didn't ask, did dinosaurs ever get sick? The answer is yes (or else it would be a super short episode). (Thanks to Llewelly for some corrections!) A big birthday shout-out to Gwendolyn! Have a great birthday! The unlocked Patreon episode about green puppies Further reading: Researchers discover first evidence indicating dinosaur respiratory infection Sauro-throat, Part 3: what does Dolly's disease tell us about sauropods? Dinosaurs got cancer Giant Dinosaur Had 2 Tumors on Its Tailbone Dinosaurs got sick, too--but from what? cough cough: Show transcript: Welcome to Strange Animals Podcast. I'm your host, Kate Shaw. This week we have a dinosaur episode, but not one you may expect. We're going to learn about some dinosaur fossils found with evidence of sickness to answer the question, did dinosaurs get sick? Yes, they did. Otherwise this episode would be about two minutes long. I know some people get squicked when they hear about illness and disease, so I've also unlocked a Patreon episode about puppies that are born green. Don't worry, the puppies are fine! There's a link in the show notes so you can click through and listen to the episode on your browser, no login needed. Before we get to the dinosaurs, we have a birthday shout-out! Happy birthday to Gwendolyn, who is turning two years old this week! Oh my gosh, Gwendolyn, you're going to learn so many new things this year! I hope you have a wonderful birthday. And now, the dinosaurs. Just a few days ago as this episode goes live, researchers announced that they'd found the fossilized remains of a young sauropod dinosaur. It lived around 150 million years ago in what is now the United States, specifically in southwestern Montana. The fossil was nicknamed Dolly by the paleontologists who studied it. Dolly was a sauropod in the family Diplodocidae, and like other sauropods the Diplodocids all had huge neck vertebrae because their necks were so long. The bones weren't solid, though, but contained air sacs that made the bones lighter and also connected to the respiratory system. This is the case in birds too. Technically the air sacs in the bones are called pneumatic diverticula, but that's hard to say so I'm just going to call them air sacs. When a bird breathes, instead of its lungs inflating and deflating, the air sacs throughout its body and bones inflate and deflate. This pumps fresh air through the lungs and allows the bird to absorb a lot more oxygen with every breath than most mammals can. The bones of Dolly's neck had unusual bony protrusions around the spaces where the air sacs once were. When the paleontologists made a CT scan of the protrusions they discovered they were abnormal bone growths that probably resulted from an infection. Sauropods share a common ancestor with birds and researchers think they might have sometimes caught a respiratory illness similar to aspergillosis [asper-jill-OH-sus], a disease common in birds and reptiles today. Dolly would have had a fever, difficulty breathing, coughing, a sore throat, and other symptoms familiar to us as flu-like or pneumonia-like. Aspergillosis can be fatal in birds, so this respiratory infection might have actually been what killed Dolly. I think we can all agree that the worst symptom to have as a sauropod, whose necks were as much as 30 feet long, or 9 meters, is a sore throat. That's not the only indication of illness in a dinosaur fossil, of course. A 2003 paper published in Nature detailed the results of a study where paleontologists scanned 10,000 dinosaur vertebrae from over 700 animals to see if any of them showed tumors. They found 97 individuals that did, all of them from around 70 million years ago and all of them hadrosaurs. Those are the duck-billed dinosaurs that were common in the late Cretaceous in many parts of the world, especially in what is now North America and Asia.
When most of us hear the word ‘CAPA', these days we more than likely immediately start thinking about SARS-CoV-2 variants, trying to remember how important this particular one was in the grand scheme of the COVID-19 pandemic. But, that is not the ‘kappa' we will be talking about today. Instead, we'll be discussing the other CAPA, or COVID-19 Associated Pulmonary Aspergillosis, and we will cover a few areas on this topic, including: - Defining what CAPA is and how prevalent it is among ICU patients with COVID-19 - Discuss why identification of invasive aspergillosis in patients with COVID-19 differs compared to other at-risk patients - Review two recent publication in JCM that discuss specific assays and diagnostic approaches for optimal detection of invasive aspergillosis in patients with COVID-19. Guests: Dr. Martin Hoengil Prof. Alexandre Alanio This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org. Follow EIC Alex McAdam on twitter for JCM updates via https://twitter.com/JClinMicro and co-host, Elli Theel at https://twitter.com/ellitheelphd. Subscribe to the podcast at https://asm.org/eic
Welcome back to the tasty morsels of critical care podcast. Today we look at everyone's favorite mould – aspergillus. We see a number of fungal infections in the ICU, most commonly it'll be the yeasts – forms of candida. Yeasts ... Read More »
ABPA, aspergilloma, semi invasive necrotising aspergilloses, invasive airspace and angio-invasive
Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis.
Aspirgillosis is a deadly fungal infection that is a major cause of mortality in patients with impaired immune systems. The current standard of care has been voriconazole due to the favorable side effect profile compared to amphotericin. However, posaconazole may not have there adverse effects and be a reasonable course of therapy. Is voriconazole just just a phase? Today's episode is sponsored by a special CEimpact FREE Law focused webinar: Save your spot - FREE LIVE LAW CE webinar on April 1st. SPOTS ARE LIMITED! https://ceimpact.com/law Reference: Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140- 6736(21)00219-1. PMID: 33549194. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages e1–e60, hMps://doi.org/10.1093/cid/ciw326 CPE details for GameChangers Podcast March 2021 Learning Objective: Develop appropriate treatment of aspergillosis infections based on clinical studies. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Aspirgillosis is a deadly fungal infection that is a major cause of mortality in patients with impaired immune systems. The current standard of care has been voriconazole due to the favorable side effect profile compared to amphotericin. However, posaconazole may not have there adverse effects and be a reasonable course of therapy. Is voriconazole just just a phase?Today's episode is sponsored by a special CEimpact FREE Law focused webinar: Save your spot - FREE LIVE LAW CEwebinar on April 1st. SPOTS ARE LIMITED!https://ceimpact.com/law Reference: Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140- 6736(21)00219-1. PMID: 33549194.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages e1–e60, hMps://doi.org/10.1093/cid/ciw326CPE details for GameChangers Podcast March 2021Learning Objective: Develop appropriate treatment of aspergillosis infections based on clinical studies.0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcastSee omnystudio.com/listener for privacy information.
Aspirgillosis is a deadly fungal infection that is a major cause of mortality in patients with impaired immune systems. The current standard of care has been voriconazole due to the favorable side effect profile compared to amphotericin. However, posaconazole may not have there adverse effects and be a reasonable course of therapy. Is voriconazole just just a phase? Today's episode is sponsored by a special CEimpact FREE Law focused webinar: Save your spot - FREE LIVE LAW CE webinar on April 1st. SPOTS ARE LIMITED! https://ceimpact.com/law Reference: Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140- 6736(21)00219-1. PMID: 33549194. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages e1–e60, hMps://doi.org/10.1093/cid/ciw326 CPE details for GameChangers Podcast March 2021 Learning Objective: Develop appropriate treatment of aspergillosis infections based on clinical studies. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.
Aspirgillosis is a deadly fungal infection that is a major cause of mortality in pateints with impaired immune systems. The current standard of care has been voriconazole due to the favorable side effect profile compared to amphotericin. However, posaconazole may not have there adverse effects and be a reasonable course of therapy. Is voriconazole just just a phase? Reference: Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140- 6736(21)00219-1. PMID: 33549194. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages e1–e60, hMps://doi.org/10.1093/cid/ciw326 CPE details for GameChangers Podcast March 2021 Learning Objective: Develop appropriate treatment of aspergillosis infections based on clinical studies. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.
The Aspergillus genus of fungi can cause a wide range of infections, depending primarily on the host's underlying health. In this episode, Andrew introduces three fictional patients all at risk for aspergillosis and describes the unique manifestation of disease in each. The major forms described include invasive aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis - with discussion on their pathogenesis, presentation, workup, and management.
Respiratory Medicine Mrcp 1
Jeremy Brown is a Respiratory Consultant at UCLH, with an interest in the lung complications patients experience following chemotherapy and stem cell transplantation. We discuss the issues caused by Bacterial Pneumonia, PCP, Fungal infections like Aspergillosis, CMV, Lung GVHD, Organising Pneumonia and TB.
In this episode we cover that not so friendly-Fingi: Aspergillus Come get acquinted with the two forms: angioinvasive (think neutropenia) vs bronchoinvasive (the not so immunosuppressed). Don't forget to add this to your Ddx for nosocomial post-influenza & COVID-19.
Today we'll talk about the many manifestations of Aspergillosis. High-yield, board-relevant information with two board-style practice questions. --- Send in a voice message: https://anchor.fm/bradleysmicroboardreview/message Support this podcast: https://anchor.fm/bradleysmicroboardreview/support
A deadly fungal disease strikes the kākāpō population on Whenua Hou and the Kākāpō Recovery team calls on New Zealand wildlife vets to help, in part 7 of Voice of the Kākāpō..
A deadly fungal disease strikes the kākāpō population on Whenua Hou and the Kākāpō Recovery team calls on New Zealand wildlife vets to help, in part 7 of Voice of the Kākāpō..
A deadly fungal disease strikes the kākāpō population on Whenua Hou and the Kākāpō Recovery team calls on New Zealand wildlife vets to help, in part 7 of Voice of the Kākāpō..
Today is World Aspergillosis Day, a day to raise awareness about a fungal infection that kills more than one million people globally each year. Joining me now to talk about aspergillosis, a new kind of antifungal drug and World Aspergillosis Day is Marco Taglietti, M.D. Dr Taglietti is the president and chief executive officer of SCYNEXIS and an infectious disease expert.
Today is World Aspergillosis Day, a day to raise awareness about a fungal infection that kills more than one million people globally each year. Joining me now to talk about aspergillosis, a new kind of antifungal drug and World Aspergillosis Day is Marco Taglietti, M.D. Dr Taglietti is the president and chief executive officer of […] The post Aspergillosis, a new kind of antifungal drug and World Aspergillosis Day appeared first on Outbreak News Today.
GB Talks about aromatherapy, and natural earthen clays, clean water, natural salves, Kennel Kelp, and THE BH Sales Power Trio- to help abate issues ranging in scope to sinusitis, rhinitis, aspergillsis, nasal obstructions , polyps and more how to treat these holistically vs Over The counter prescribed meds!! Brachy means shortened and cephalic means head. Therefore, brachycephalic dogs have skull bones that are shortened in length, giving the face and nose a pushed in appearance. Due to the shorter bones of the face and nose, the anatomy and relationship with the other soft tissue structures are altered; some of these changes can cause physical problems for the affected dog. Mildly affected dogs will have noisy breathing, especially with exercise, and most will snort when excited and snore when relaxed or asleep. Severely affected dogs have more pronounced airway noise, appear to tire easily with exercise, and may collapse or faint after exercise. Other signs may include coughing, gagging, retching, and vomiting. Signs are often worse in hot or humid weather. Dogs with impacts to their gastrointestinal tract may show signs including retching, vomiting, or lack of appetite. Over time, dogs with this syndrome may develop other secondary problems, including inflammation of other structures in the airways. In the long term, the increased effort associated with breathing can put an increased strain on the heart. Most dogs are diagnosed with brachycephalic airway syndrome between 1 and 4 years of age. Both males and females appear to be affected equally. Dogs with multiple abnormalities tend to develop problems at an earlier age. Aspergillosis is an infection caused by the Aspergillus fungus, which is commonly found in the environment in substances such as dust, hay, and grass. The nasal form of the disease is usually seen in outdoor and farm dogs because there more frequently exposed to the substances in which the fungus Aspergillus is found. Birds are the most common source of infection in humans. While the potential to contract aspergillosis from your dog exists, it is less likely if you practice good personal hygiene, especially hand washing and avoid handling any discharges. Treatment for aspergillosis depends on which type of fungal infection the dog has. If the dog has nasal aspergillosis, then an antifungal medication will be prescribed and administered directly into his nasal passages while under sedation --- Send in a voice message: https://anchor.fm/bhsales/message
The kākāpō chicks are graduating to being juveniles and only seven birds are still sick with aspergillosis, in ep 23 of the Kākāpō Files.
The kākāpō chicks are graduating to being juveniles and only seven birds are still sick with aspergillosis, in ep 23 of the Kākāpō Files.
The kākāpō chicks are graduating to being juveniles and only seven birds are still sick with aspergillosis, in ep 23 of the Kākāpō Files.
Kākāpō death toll from aspergillosis rises by one to seven, while nine birds have been given a clean bill of health. Sad and positive news from the frontline of the fight to save kākāpō, in ep 20 of the Kākāpō Files.
Kākāpō death toll from aspergillosis rises by one to seven, while nine birds have been given a clean bill of health. Sad and positive news from the frontline of the fight to save kākāpō, in ep 20 of the Kākāpō Files.
Kākāpō death toll from aspergillosis rises by one to seven, while nine birds have been given a clean bill of health. Sad and positive news from the frontline of the fight to save kākāpō, in ep 20 of the Kākāpō Files.
Many of Wellington's streams now run in pipes under the roads, and the aspergillosis crisis in the kakapo population grows.
Many of Wellington's streams now run in pipes under the roads, and the aspergillosis crisis in the kakapo population grows.
The number of cases of aspergillosis in the kākāpō population continues to rise, with 30 birds on the mainland for testing & treatment. The deaths of Huhana and Merty drop the adult population to 142, in ep 19 of the Kākāpō Files.
The number of cases of aspergillosis in the kākāpō population continues to rise, with 30 birds on the mainland for testing & treatment. The deaths of Huhana and Merty drop the adult population to 142, in ep 19 of the Kākāpō Files.
The number of cases of aspergillosis in the kākāpō population continues to rise, with 30 birds on the mainland for testing & treatment. The deaths of Huhana and Merty drop the adult population to 142, in ep 19 of the Kākāpō Files.
A spate of kākāpō chicks deaths from a fungal pneumonia caused by aspergillosis has DOC's Kākāpō Recovery Team very worried. Two further adult deaths bring the population to 144 birds with 73 living chicks, all in ep 18 of the Kākāpō Files.
A spate of kākāpō chicks deaths from a fungal pneumonia caused by aspergillosis has DOC's Kākāpō Recovery Team very worried. Two further adult deaths bring the population to 144 birds with 73 living chicks, all in ep 18 of the Kākāpō Files.
A spate of kākāpō chicks deaths from a fungal pneumonia caused by aspergillosis has DOC's Kākāpō Recovery Team very worried. Two further adult deaths bring the population to 144 birds with 73 living chicks, all in ep 18 of the Kākāpō Files.
Pulmonary Aspergillosis for the FRCR 2a Exam
En el programa de esta semana hablamos sobre el riesgo de aspergilosis pulmonar invasiva en pacientes con infecciones aguda severa por influenza con falla respiratoria. Referencias: Schauwvlieghe AFAD, Rijnders BJA, Philips N y colaboradores. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018; Publicado online julio 31, 2018. Frederic Lamoth y Thierry Calandra. Let's add invasive aspergillosis to the list of influenza complications. Lancet Respir Med 2018. Nancy F Crum-Cianflone. CInvasive Aspergillosis Associated with Severe Influenza Infections. Open Forum Infect Dis. Agosto 2016. Frase de la Semana: Esta semana la tomamos de Maria Zambrano Alarcon. Nacio el 22 de abril de 1904, en Vélez-Málaga y Fallecio el 6 de febrero de 1991, en Madrid. Fue una ensayista, filósofa y humanista española asociada a la Generación del '36. Fue galardonada con el Premio Príncipe de Asturias (1981) y el Premio Miguel de Cervantes (1988) siendo la primera mujer en recibirlo. La frase dice: “No se pasa de lo posible a lo real, sino de lo imposible a lo verdadero”
Bart Rijnders joins The Lancet Respiratory Medicine to discuss his new paper on patients with severe influenza developing invasive pulmonary aspergillosis.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of an original article on chronic pulmonary aspergillosis in advanced pulmonary sarcoidosis with Prof. David Denning from the National Aspergillosis Centre at the University Hospital of South Manchester and the University of Manchester, UK.
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the new ESCMID/ERS guidelines for the diagnosis and management of chronic pulmonary aspergillosis with Prof. David W. Denning from the University of Manchester, UK.
Episode 1035. Today, I welcome back Peter Brown, aka The Chicken Doctor to teach us all about Aspergillosis! Backyard Poultry with the Chicken Whisperer®, brought to you by Kalmbach Feeds, is a nationally broadcast web radio show all about keeping backyard poultry, show poultry, and living a self-sufficiant lifestyle. Each week, the Chicken Whisperer®, Editor In Chief of, Chicken Whisperer Magazine, Author of, The Chicken Whisperer's Guide To Keeping Chickens, and National Spokesperson for the USDA-APHIS Biosecurity for Birds Program, welcomes experts in their field from around the country to share their knowledge about backyard poultry, show poultry, and living a self-sufficiant lifestyle. Regular guests include, poultry scientist and professor, Dr. Brigid McCrea, Ph.D., Peter Brown, aka The Chicken Doctor, Alexandra Douglas, aka The Quail Lady, Jeannette Beranger, with the American Livestock Breeds Conservancy, Richard Freudenberger, Publisher of Back Home Magazine, and Traci Kennebeck, with Purple Lotus Essential Oils. Other guests include, but are not limited to, FFA members, 4H members, poultry club members, and the who's who in the backyard poultry, show poultry, and self-sufficiant lifestyle industries. The Backyard Poultry with the Chicken Whisperer® web radio show has given away more chicken coops, and chicken related prizes than anyone else on the planet! Tune in to learn more about your backyard chickens from the experts!
Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)
Volume 2, Issue 4.In this edition Dr. Richard Moss will help expand our understanding of allergic bronchopulmonary aspergillosis (ABPA) with the discussion some typical case scenarios. ABPA is a major pulmonary complication in patients with cystic fibrosis (CF). The impact of ABPA on the course of CF lung disease poses special challenges, with chronic Aspergillus respiratory infection, even in the absence of ABPA, playing a significant role, according to data from 2 recent retrospective cohort studies. Dr. Moss' use of current diagnostic criteria provides perspective also on the limitations.The post Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA) appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.
eCystic Fibrosis Review:Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)
© 2020-2025 Ivy Podcast Discovery LLC
